Standex International Corp/de/ Form 4 insider transactions
NYSE
Standex International's VP/CFO/Treasurer, Ademir Sarcevic, sold 1,085 shares of common stock for approximately $209.86 per share on August 26, 2025, under a Rule 10b5-1 plan.
NYSE
Standex International's VP & Chief Accounting Officer, Danielle Rangel, reported the vesting of restricted stock units, tax-related share sales, and new equity awards.
NYSE
Standex International Corp's CLO, VP & Secretary, Alan J. Glass, reported multiple acquisitions of common stock through vesting and subsequent sales for tax obligations, alongside new equity awards.
NYSE
Annemarie Bell, VP and Chief HR Officer at Standex International, reported vesting of equity awards and subsequent tax-related share sales.
NYSE
Standex International's President, CEO, and Chairman, David A. Dunbar, reported the vesting of various equity awards and subsequent tax-related share dispositions, alongside new equity grants.
NYSE
Standex International's CFO, Ademir Sarcevic, reported scheduled vesting of equity awards and subsequent tax-related stock sales, alongside new performance and restricted stock unit grants.
NYSE
Standex International's VP and CIO, Max Arets, reported the vesting of restricted stock units, a tax-related share sale, and new equity awards.
NYSE
Standex International Director Barbara Joanne Edwards acquired 387 shares of common stock through the vesting of phantom stock units and received a new grant of 209 phantom stock units.
NYSE
Standex International Director Thomas J. Hansen reported the vesting of 1,107 phantom stock units and the acquisition of 599 new phantom stock units under company plans.
NYSE
Standex International Director Andy L. Nemeth acquired 2,000 shares of common stock at a weighted average price of $209.4959 per share.
NYSE
Standex International Director Robin J. Davenport was granted 149 phantom stock units, vesting in three years, under the company's incentive plan.
NYSE
Standex International Director Charles H. Cannon Jr. acquired 599 phantom stock units under the company's incentive plan.
NYSE
Standex International's VP and Chief Information Officer, Max Arets, increased his beneficial ownership of common stock through the company's Dividend Reinvestment Plan.
NYSE
Standex International Director Robin J. Davenport acquired additional common stock through the company's Dividend Reinvestment Plan.
NYSE
Standex International Director Thomas J. Hansen sold 2,992 shares of common stock for approximately $202.60 per share on August 18, 2025, under a pre-arranged trading plan.
NYSE
Standex International's President and CEO, David A. Dunbar, reported a future sale of 16,000 shares of common stock at $200 per share under a pre-arranged 10b5-1 trading plan.
NYSE
An amended SEC Form 4 clarifies that a recent sale of 2,779 Standex International shares was executed by a trust, not directly by Director Charles H. Cannon Jr.
NYSE
Standex International's CFO, Ademir Sarcevic, sold 3,047 shares of common stock for approximately $191.80 per share, as part of a pre-arranged Rule 10b5-1 plan.
NYSE
Max Arets, VP and Chief Information Officer of Standex International Corp, acquired 28 shares of common stock at $133.008 per share through the company's Employee Stock Purchase Plan.
NYSE
Danielle Rangel, VP & Chief Accounting Officer at STANDEX International, acquired 9 shares of common stock at $133.008 per share through the company's Employee Stock Purchase Plan.
NYSE
Director Barbara Edwards gifted shares to a donor advised fund and the fund subsequently sold shares of Standex International.
NYSE
Director Charles H. Cannon Jr. reports a transaction involving Standex International Corp. stock.
NYSE
VP and Chief Information Officer of Standex International, Max Arets, reports disposing of 144 shares of common stock to cover tax liabilities associated with vesting restricted stock on April 8, 2025.
NYSE
Vice President/CFO/Treasurer of Standex International Corp, Sarcevic Ademir, reports the forfeiture of 1,716 common stock shares to cover tax liabilities.
NYSE
Max Arets, VP and Chief Information Officer of Standex International Corp., purchased 63 shares of common stock at $191 per share on February 12, 2025.
NYSE
Ademir Sarcevic, Vice President/CFO/Treasurer of Standex International Corp., sold 2,000 shares of common stock at an average price of $195.436 on February 10, 2025.
NYSE
Charles H. Cannon Jr., a director at Standex International, transferred 1,118 shares of common stock to the Cannon Family Trust.
NYSE
A Standex International Corp executive, Ademir Sarcevic, sold 1,600 shares of common stock at an average price of $199.81.
NYSE
Director Thomas Hansen of Standex International Corp sold 1,661 shares of common stock on November 11, 2024, at an average price of $210.4148.
NYSE
Ademir Sarcevic, Vice President/CFO/Treasurer of Standex International Corp., sold 3,800 shares of common stock at a weighted average price of $181.6448 on November 4, 2024.